PEAK6 Investments’s Amedisys AMED Stock Holding History

PEAK6 Investments’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,486	Closed	-$1.87M	–	5127
2021 Q4	$2.02M	Sell	12,486 -40,865	-77%	-$6.57M	﹤0.01%	1883
2021 Q3	$7.96M	Buy	53,351 +48,207	+937%	+$10M	0.02%	840
2021 Q2	$1.26M	Sell	5,144 -6,806	-57%	-$1.79M	﹤0.01%	2338
2021 Q1	$3.16M	Buy	11,950 +9,809	+458%	+$2.77M	0.01%	1445
2020 Q4	$628K	Buy	+2,141	New	+$549K	﹤0.01%	2896
2020 Q2	–	Sell	-9,078	Closed	-$1.69M	–	4329
2020 Q1	$1.67M	Buy	+9,078	New	+$1.62M	0.01%	1156
2019 Q4	–	Sell	-47,552	Closed	-$7.07M	–	3331
2019 Q3	$6.23M	Buy	47,552 +29,075	+157%	+$3.79M	0.04%	573
2019 Q2	$2.24M	Buy	+18,477	New	+$2.19M	0.01%	1201
2019 Q1	–	Sell	-4,434	Closed	-$519K	–	3756
2018 Q4	$519K	Buy	+4,434	New	+$523K	﹤0.01%	2307

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

PEAK6 Investments's AMED Position: Q1 2022 in Review

PEAK6 Investments sold out of Amedisys (AMED) in Q1 2022, closing a stake of 12,486 shares — an estimated $1.87M sold.

PEAK6 Investments first reported a position in AMED in Q4 2018 and held it in 9 quarters. The position peaked at $7.96M in Q3 2021. 328 funds tracked by Wall St. Rank hold AMED as of Q1 2022.

PEAK6 Investments reported no remaining Amedisys position as of Q1 2022 after selling out during the quarter.
PEAK6 Investments sold 12,486 Amedisys shares in Q1 2022, an estimated $1.87M.
PEAK6 Investments first reported a position in Amedisys in Q4 2018 and held it in 9 quarters.
PEAK6 Investments's Amedisys position peaked at $7.96M in Q3 2021.
328 funds tracked by Wall St. Rank held Amedisys as of Q1 2022.

Based on PEAK6 Investments's 13F filing for Q1 2022, filed 13 May 2022.